InvestorsHub Logo
Followers 17
Posts 3780
Boards Moderated 0
Alias Born 02/21/2009

Re: Chaka post# 14036

Thursday, 09/22/2016 9:46:34 AM

Thursday, September 22, 2016 9:46:34 AM

Post# of 64388
Nutra Pharma's MS drug is real. The fact that the FDA granted them an Orphan Designation is real.

NPHC has finally brought in solid management to move things forward - Dan Oran for retail sales, Dale Vanderputten for the FDA stuff and General Dowd for VA and government.

Dr. Vanderputten comes to us with over 30 years of management and clinical experience with governmental agencies as well as private sector biotech.

Dan Oran has more than 27 years of experience as a successful business owner in the US and Israel with extensive knowledge of finances, sales and cost management skills.

Maj. Gen. Kenneth Dowd, US Army (Ret.) wil be a Strategic Advisor for the Company's newly created 'Military & Veterans' business segment. General Dowd will support Nutra Pharma's efforts in presenting the Company's non-opiate, non-narcotic over-the-counter (OTC) pain solution, Nyloxin® to the US Military and the Veteran's Administration.

NPHC is listed on the OTCQB which provides more credibility than the pinksheets.